The Claim
In healthy human skin exposed to ultraviolet-B radiation, eicosapentaenoic acid (EPA) is associated with reduced prostaglandin-E2 production, with no association observed between EPA and changes in interleukin-1β, tumor necrosis factor–α, interleukin-6, or interleukin-8 levels.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In human skin exposed to UV-B radiation, eicosapentaenoic acid (EPA) is linked to lower levels of prostaglandin-E2, but it is not linked to changes in interleukin-1β, tumor necrosis factor–α, interleukin-6, or interleukin-8.
See the scientific wording
In healthy human skin exposed to ultraviolet-B radiation, eicosapentaenoic acid (EPA) is associated with the abrogation of prostaglandin-E2 production, suggesting a potential role in modulating inflammatory pathways, though no evidence links this effect to changes in interleukin-1β, tumor necrosis factor–α, interleukin-6, or interleukin-8 levels.
When EPA enters skin cells, it replaces a similar fat called arachidonic acid in the cell membranes. When the skin is exposed to UV-B radiation, enzymes use arachidonic acid to make prostaglandin-E2, which causes inflammation. EPA blocks those enzymes from using arachidonic acid, so less prostaglandin-E2 is made. This does not affect other inflammatory signals like interleukin-1β, tumor necrosis factor–α, interleukin-6, or interleukin-8.
What the research says
1 studyIn human skin exposed to sunlight, EPA helps reduce one inflammation chemical (PGE2) but doesn’t change other inflammation signals like IL-6 or TNF-alpha — and the study directly showed this.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.